Premier platinum hpsa plus kits
Ended Definitive Contract Awarded Last action
- Contract number
- W91YTZ16C0018
- Awardee
-
Meridian Bioscience Inc. UEI HWJ5BXUMNGK5
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $148,222
Award facts
- Opportunity
-
- W91YTZ16R0083 Solicitation number
- H-Pylori Test Kits w/ Microplate Reader Award Notice · Posted Sep 10, 2016
- "Brand Name or Equal" H-Pylori Test Kits w/ Microplate Reader Award Notice · Posted Jul 27, 2016
- Contract value 54% obligated
-
- $148,221.86 Current, with exercised options
- $274,884.11 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Cincinnati, OH 45244, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$28,270 | |
| Funding Only Action | $60,578 | |
| Exercise an Option | $0 | |
| Funding Only Action | $58,813 | |
| Exercise an Option | $0 | |
| Funding Only Action | $57,100 | |
| Original award | $0 |
About this award
This is a definitive contract awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense to Meridian Bioscience Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic test kits, reagents, and instruments. The contract, valued at $274,884.11, is for the supply of "PREMIER PLATINUM HPSA PLUS KITS" with a completion date of September 30, 2021. The contract is a firm fixed-price arrangement. Meridian Bioscience Inc. is a key supplier of diagnostic solutions to various federal agencies, including the Department of Defense, Department of Veterans Affairs, Department of State, and Department of Health and Human Services. The company has also been involved in research and development projects related to rapid point-of-care testing technologies for COVID-19, funded by the National Institutes of Health. This contract award does not have a set-aside designation.
Quick answers
Who was awarded contract W91YTZ16C0018?
W91YTZ16C0018 was awarded to Meridian Bioscience Inc. by Medical Command (Department of the Army) on October 1, 2016.
How much is contract W91YTZ16C0018 worth?
The government has obligated $148,222 on W91YTZ16C0018. Its potential value, with all options, is $274,884.
Was contract W91YTZ16C0018 competed?
The extent of competition for W91YTZ16C0018 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award